Management and tolerability of glecaprevir‐pibrentasvir pharmacotherapy in hepatitis C viremic heart and lung transplant recipients-Reference-Cited by-同舟云学术

Management and tolerability of glecaprevir‐pibrentasvir pharmacotherapy in hepatitis C viremic heart and lung transplant recipients

Published:2020-07-24 Issue:10 Volume:34 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Lewis Tyler C.¹^ORCID,Gidea Claudia²^ORCID,Reyentovich Alex²^ORCID,Angel Luis³,Lesko Melissa³,Pavone Jennifer³,Sureau Kimberly³,Smith Deane E.⁴,Kon Zachary⁴,Moazami Nader⁴

Affiliation:

1. Department of Pharmacy NYU Langone Health New York New York USA

2. Department of Cardiology NYU Langone Health New York New York USA

3. Transplant Institute NYU Langone Health New York New York USA

4. Department of Cardiothoracic Surgery NYU Langone Health New York New York USA

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14030

Reference23 articles.

1. OPTN/SRTR 2017 Annual Data Report: Heart

2. OPTN / SRTR 2018 Annual Data Report: Lung

3. Current Use of Hearts From Hepatitis C Viremic Donors

4. The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States

5. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney transplantation: Assessment of the Kidney Donor Candidate;Living Donor Organ Transplantation;2024

2. Heart transplantation: advances in expanding the donor pool and xenotransplantation;Nature Reviews Cardiology;2023-07-14

3. The SHELTER Trial of Transplanting Hepatitis C Virus–Infected Lungs Into Uninfected Recipients;Transplantation Direct;2023-06-28

4. Beyond donation to organ utilization in the USA;Current Opinion in Organ Transplantation;2023-03-09

5. A systematic review of direct acting antiviral therapies in hepatitis C virus‐negative liver transplant recipients of hepatitis C‐viremic donors;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-11-25